Gabelli Funds’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Gabelli Funds’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-186,900	Closed	-$8.68M	–	1182
2023 Q2	$8.68M	Buy	+186,900	New	+$6.46M	0.07%	334

Gabelli Funds's DICE Position: Q3 2023 in Review

Gabelli Funds sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 186,900 shares — an estimated $8.68M sold.

Gabelli Funds first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $8.68M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Gabelli Funds reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Gabelli Funds sold 186,900 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $8.68M.
Gabelli Funds first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Gabelli Funds's DICE Therapeutics, Inc. Common Stock position peaked at $8.68M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Gabelli Funds's 13F filing for Q3 2023, filed 8 Nov 2023.